Tampere University of Technology / ELT Dept
Welcome,         Profile    Billing    Logout  
 1 Trial 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Karjalainen, Jussi
NIMBLE, NCT04718389 / 2020-003612-28: A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype

Hourglass Feb 2024 - Jun 2024 : Acceptance of regulatory submission in China for CRSwNP
Active, not recruiting
3
1667
Europe, Canada, Japan, US, RoW
GSK3511294 (Depemokimab), Mepolizumab, Benralizumab, Placebo, Standard of care (SoC), Pre-filled Syringes (PFS)
GlaxoSmithKline, Iqvia Pty Ltd
Asthma
10/25
10/25
NCT03718793: Small Airway Inflammation and Dysfunction in Different Asthma Phenotypes

Recruiting
N/A
160
Europe
Peripheral exhaled nitric oxide, Impulse oscillometry, ECP/B-eos ratio
Tampere University Hospital
Asthma
12/24
12/24
NCT05740163: Oral Immunotherapy for Egg Allergy in Children Aged 6 to 16

Recruiting
N/A
60
Europe
Egg product including egg white and yolk allergens
Tampere University Hospital, University of Oulu, Oulu University Hospital
Egg Allergy
12/24
12/26

Download Options